Status:
COMPLETED
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
Lead Sponsor:
Pfizer
Conditions:
Arthritis, Psoriatic
Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the safety profile and the effectiveness of etanercept under usual care settings in patients with PsA treated by dermatologists.
Detailed Description
Non-interventional study: subjects to be selected according to the usual clinical practice of their physician
Eligibility Criteria
Inclusion
- Clinical diagnosis of Psoriatic Arthritis
Exclusion
- Sepsis or risk for sepsis,
- Acute infection,
- Hypersensitive against Etanercept
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT00293709
Start Date
January 1 2006
End Date
February 1 2013
Last Update
February 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
München, Germany, 81377